TEOXANE Italia

Restare aggiornati è essenziale. Iscriviti alla newsletter Teoxane: http://eepurl.com/hX5uaL per accesso esclusivo a nuove scoperte e risorse nel campo della Medicina Estetica. La tua conoscenza è la tua forza. Iscriviti ora! #TeoxaneItalia #Newsletter #aggiornamento #formazione

All'interno della piattaforma Teoxane Academy Digital scopri il nostro canale di Educazione Continua in Medicina (ECM). Sull'app Xpeer, offriamo moduli di apprendimento accreditati, approvati dall'European Accreditation Council for Continuing Medical Education (EACCME). Visualizzando e completando un test di valutazione, dal telefono o dal portatile, è possibile ottenere crediti ECMEC validi in 26 Paesi! #Teoxane #MedicalEducation

We are deeply honored to announce that Teoxane has been recognized as one of "Switzerland's Best Managed Companies" for the second year in a row! This esteemed recognition, awarded by Deloitte, was presented during a ceremony in Zurich on June 27th, 2024. For over 20 years our success has been driven by three core objectives: - Innovation: Constantly evolving to stay ahead of market demands. - Safety & Satisfaction: Prioritizing the well-being of patients and the satisfaction of practitioners. - Global Excellence: Aiming for the highest standards in every facet of our global operations. This award is a testament to the hard work and dedication of our exceptional teams and the trust of our valued partners and clients. #Teoxane #BestManagedCompanies #Deloitte #Innovation #Excellence #Healthcare #MedicalEducation

Excited to share that last May, Teoxane presented the Teoxane Midface Volume Deficit Scale (TMVDS) at the SCALE Congress in Nashville, a new milestone in our commitment to advancing aesthetic medicine. The TMVDS is a 5-grade photonumeric scale that assesses midface volume deficit, helping to address issues of aging and tissue loss in the central face. By providing a reliable and sensitive tool for clinical trials and everyday practice, we continue to empower practitioners with the means to deliver exceptional care. This scale, along with our previous Lip Fullness and Infra-Orbital Hollow scales, showcases our dedication to precise and meaningful aesthetic assessments. Je suis fière de partager la présentation de la Teoxane Midface Volume Deficit Scale (TMVDS) au congrès SCALE à Nashville, marquant une nouvelle étape dans notre engagement à faire avancer la médecine esthétique.  La TMVDS est une échelle photo numérique en 5 grades qui évalue le déficit de volume du tiers moyen du visage, contribuant à résoudre les problèmes de vieillissement et de perte de tissu dans cette zone. En fournissant un outil fiable et précis pour les essais cliniques et la pratique quotidienne, nous continuons à doter les praticiens des moyens nécessaires pour offrir des soins exceptionnels. Cette nouvelle introduction, au même titre que nos précédentes échelles développées pour le volume des lèvres et le cerne creux, témoigne de notre dévouement envers des évaluations esthétiques rigoureuses.

For over 10 years, TEOXANE Laboratories has been the first and only company in the world to create a dermal filler specifically designed for the sensitive and delicate tear trough area. A recent study commissioned by Teoxane and conducted by IPSOS across four European markets reveals that dark circles are a major concern for 48% of respondents. Surprisingly, many people are still poorly informed about this issue and often resort to ineffective remedies. The tear trough is a very specific anatomical area affected by various factors such as heredity, pigmentation, lifestyle, and aging. For hollow under-eye circles, our product Teosyal® Puresense Redensity 2 is specifically formulated to meet the needs of this delicate area. Despite the low penetration of injectable treatments in this area, those who opt for this solution report significantly higher satisfaction. Depuis plus de 10 ans, Teoxane a été la première et la seule entreprise au monde à avoir créé un produit de comblement dermique spécialement conçu pour la zone sensible et délicate des cernes. Une récente étude commandée par Teoxane et réalisée par Ipsos dans quatre marchés européens révèle que les cernes représentent une préoccupation majeure pour 48% des personnes interrogées. Étonnamment, beaucoup de gens demeurent mal informés sur ce sujet et ont souvent recours à des remèdes inefficaces. La vallée des larmes est une zone anatomique très spécifique, affectée par divers facteurs tels que l'hérédité, la pigmentation, le mode de vie et le vieillissement. Teosyal® Puresense Redensity 2 est né de ce constat et a été spécialement formulé pour répondre aux besoins de cette zone délicate.  Malgré le faible taux de recours aux traitements injectables pour cette zone, les personnes qui le font expriment généralement une grande satisfaction à l'égard des résultats obtenus.

Oggi non perdere il Tag Live "Advancing Periorbital Treatments: The Teoxane Approach" con dr Lee Walker e dr. Sabrina Shah-Desai. Registrati subito: https://lnkd.in/d7PdqZxU Ti aspettiamo!

Con i nostri webinar esclusivi, scoprirai i segreti degli esperti, insieme ai trucchi e ai consigli per evitare e gestire le complicanze nei trattamenti periorbitali. Registrati subito: https://lnkd.in/d7PdqZxU

Martedì 18 giugno, dalle 15 alle 16, non perdere l'esclusivo Tag Live "Advancing Periorbital Treatments: The Teoxane Approach" con KOLs internazionali quali dr Lee Walker e dr. Sabrina Shah-Desai. Registrati subito: https://lnkd.in/d7PdqZxU

Oggi non perdere il Tag Live "Advancing Periorbital Treatments: The Teoxane Approach" con dr Lee Walker e dr. Philippe Berros. Registrati subito: https://lnkd.in/dcrHK6vW Ti aspettiamo!

Scopri le esperienze personali degli esperti, i trucchi e i consigli per evitare/gestire le complicanze nei trattamenti periorbitali con la nostra serie di webinar esclusivi, presentati da Teoxane. Registrati subito: https://lnkd.in/dcrHK6vW